IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation

Tristan V. M. Bruijn, Anne Geraedts, Carmen A. Vlahu, Lies.H. Jaspars, Yannick S. Elshot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)41-43
Number of pages3
JournalJAAD Case Reports
Volume47
DOIs
Publication statusPublished - 1 May 2024

Keywords

  • IgA
  • anti-PD-1
  • drug eruption
  • immune checkpoint inhibitor
  • immune-related adverse event
  • pembrolizumab
  • pemphigus

Cite this